Cargando…
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
BACKGROUND: The National Centre for Pharmacoeconomics (NCPE) is a National HTA Agency in Ireland responsible for assessment of comparative clinical effectiveness, cost-effectiveness and potential budget impact of drugs on behalf of the Health Service Executive. This research aims to assess if the bu...
Autores principales: | Lamrock, Felicity, McCullagh, Laura, Tilson, Lesley, Barry, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366580/ https://www.ncbi.nlm.nih.gov/pubmed/32232603 http://dx.doi.org/10.1007/s10198-020-01181-0 |
Ejemplares similares
-
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
por: Leahy, Joy, et al.
Publicado: (2020) -
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017
por: Usher, Cara, et al.
Publicado: (2019) -
Health Technology Assessment of Drugs in Ireland: An Analysis of Timelines
por: Connolly, Emma, et al.
Publicado: (2019) -
The Utility of a Rapid Review Evaluation Process to a National HTA Agency
por: Varley, Áine, et al.
Publicado: (2021) -
Health technology management: the experience of a managed access approach to the reimbursement of dupilumab in Ireland
por: Barrett, Rosealeen, et al.
Publicado: (2023)